Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Få överraskningar i rapporten

Pledpharmas kvartalsrapport bjöd inte på några stora nyheter men planerna på diskussioner med FDA och potentiella samarbetspartners ligger fast.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Seminar program Biotech Forum

Here is the entire seminar program at Biotech Forum September 28-29th

Raysearch igång i Kina

Första patienten ombord i strålstudie.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

Stöd till kvinnliga forskare

17 kvinnliga forskare får halva lönen betald för att jobba i en ledande forskningsmiljö i Vinnova-programmet Vinnmer.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Släpper aptitretande rapport

Stockholm Business Region släpper rapport om onkologi för att locka investerare till Stockholm-Uppsalaregionen. – Rapporten ska vara en aptitretare, förklarar Ylva Hultman.

Smarta män tar sin medicin

Generell kognitiv förmåga har visat sig spela roll för hur väl män tar sin ordinerade medicin efter en hjärtinfarkt. Det visar en ny studie från Umeå och Uppsala universitet.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Planerar det regulatoriska arbetet

Anna Törner från SDS ska stötta Lidds med den regulatoriska planen för bolagets läkemedelskandidat mot prostatacancer, där en fas IIb-studie är på gång.

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

LEO Pharma - International Clinical Trial Manager

Aprea sparkar igång studie

Första patienten doserad i fas Ib/II-studien med cancerbehandlingen APR-246.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

820 miljoner till medicinsk forskning

359 projekt inom området för medicin får pengar från Vetenskapsrådet i år. I snitt kammar varje projekt hem 670 000 kronor i årets runda.

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.